Methodology

All entries for: Schrödinger Inc.

October 21, 2025

Schrödinger Inc.

Orphan Drug Designation

FDA orphan drug designation: treatment of Waldenstrom’s macroglobulinemia

Disease Area: Rare Diseases
Source
Facebook Linkedin
Main Menu
Scroll to Top